Growth Metrics

Moderna (MRNA) Asset Utilization Ratio (2019 - 2025)

Moderna (MRNA) has disclosed Asset Utilization Ratio for 5 consecutive years, with 0.25 as the latest value for Q1 2025.

  • On a quarterly basis, Asset Utilization Ratio changed N/A to 0.25 in Q1 2025 year-over-year; TTM through Mar 2025 was 0.25, a N/A change, with the full-year FY2022 number at 0.76, down 33.94% from a year prior.
  • Asset Utilization Ratio was 0.25 for Q1 2025 at Moderna, down from 0.86 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.86 in Q1 2022 to a low of 0.25 in Q1 2025.
  • A 3-year average of 0.55 and a median of 0.56 in 2021 define the central range for Asset Utilization Ratio.
  • Peak YoY movement for Asset Utilization Ratio: skyrocketed 859.95% in 2021, then skyrocketed 216.86% in 2022.
  • Moderna's Asset Utilization Ratio stood at 0.81 in 2021, then increased by 6.71% to 0.86 in 2022, then crashed by 71.44% to 0.25 in 2025.
  • Per Business Quant, the three most recent readings for MRNA's Asset Utilization Ratio are 0.25 (Q1 2025), 0.86 (Q1 2022), and 0.81 (Q4 2021).